TFS HealthScience: Katarina Ageborg and Markus Granlund Take Key Leadership Roles
Portfolio - People | Feb 20, 2025 | Ratos
Ratos, a Swedish private equity firm, has announced significant leadership changes at its portfolio company, TFS HealthScience. Katarina Ageborg, previously part of AstraZeneca's senior management, has been appointed as the new Chairman of the Board at TFS HealthScience. Markus Granlund is stepping into the role of acting CEO, bringing with him extensive leadership experience from his tenure as CEO of Semcon. The changes are set to guide TFS, a global Contract Research Organisation, through strategic development within the life sciences sector, supporting biotechnology and pharmaceutical companies. Anders Slettengren of Ratos highlights the strategic importance of these appointments, as both leaders bring significant expertise to their new roles.
Sectors
- Life Sciences
- Private Equity
- Healthcare
Geography
- Sweden – Ratos is a Swedish business group and the leadership changes pertain to its management strategies.
- Global – TFS HealthScience offers clinical research services worldwide, affecting the broader international biotechnology and pharmaceutical sectors.
Industry
- Life Sciences – TFS HealthScience operates in the life sciences industry by providing clinical research services to biotechnology and pharmaceutical companies.
- Private Equity – Ratos, the private equity firm, manages multiple portfolio companies and is involved in strategic appointments to enhance its investments.
- Healthcare – TFS HealthScience supports healthcare advancements through its clinical research and development services globally.
Financials
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| TFS HealthScience | Target Company | Company | A global Contract Research Organisation supporting biotechnology and pharmaceutical companies. |
| Ratos | Private Equity Firm | Company | A Swedish business group managing TFS HealthScience among other companies. |
| Katarina Ageborg | New Chairman of the Board | Person | Brings 25 years of experience from Astra Zeneca to lead TFS HealthScience. |
| Markus Granlund | Acting CEO | Person | Former CEO of Semcon, now acting CEO of TFS HealthScience with international customer leadership experience. |
| Bassem Saleh | Former CEO | Person | Former CEO of TFS HealthScience, departing for new opportunities. |
| Anders Slettengren | Current Chairman of TFS Board | Person | Executive Vice President at Ratos and former Chairman who worked closely with Markus Granlund. |